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Foreword
This dissertation describes the work performed under the supervision of Dr. Cla´udio M.
Gomes, in the Protein Biochemistry Folding and Stability Laboratory, at the Instituto
de Tecnologia Qu´ımica e Biolo´gica, from September 2010 to September 2011.
The studies presented here aim at understanding the role of metal ions such as Ca2+,
Cu2+ and Zn2+, in conformation and stability of S100B cytokine. It intends to clarify also
the metal-dependent mechanisms through which the structure and biological function of
S100B protein occurs.
The thesis is organized in four parts. The first chapter presents the state of the art
on fundamental aspects of protein folding, metal ions in biology and their interplay.
Moreover, it presents an overview of S100 proteins and in particular S100B, the system
in study. The following chapter includes an overview of the biophysical methods used to
monitor protein conformational stability and also the procedures performed during this
work. The third chapter reports the main experimental results obtained in the study of
S100B conformation and stability modulation by metal ions. The last chapter highlights
the general conclusions of the described results and future perspectives.
i

Abstract
S100B is a Ca2+, Cu2+ and Zn2+-binding protein highly expressed in human brain, with a
intra and extracellular function. It is involved in several pathological processes in which
metal homeostasis is imbalanced, such as AD and ALS, which account for a modified
protein function. Metal binding to S100B induces conformational changes. However,
the mechanisms underlying this modulation and how it affects protein stability remain
uncharacterized. Here, we extensively address the effects of metal binding on the folding
and stability of S100B. The physiological environment in which S100B accumulates,
such as the synaptic cleft, is metal ion rich so the protein–metal interplay is relevant
to understand S100B physiological (and pathophysiological) role. With this purpose we
have studied the native form of human S100B as well as a Cys-to-Ser mutated variant,
S100B ∆Cys, which abolishes metal bonding.
Our results showed that Cu2+ and Zn2+-binding is responsible for substantial modi-
fications in protein conformation affording secondary structure changes and promoting
aggregation. Thermal unfolding experiments indicated that Cu2+ and Zn2+ have the abil-
ity to destabilize the protein (apo-no aggregation, Cu2+-Tagg=68
◦C, Zn2+-Tagg=65◦C)
leading to a total loss of secondary structure and protein aggregation. Ca2+-binding does
not have a large effect on S100B conformation and stability, yielding a mixture of α-helix
and β-sheet secondary structure after denaturation, without forming aggregates. The
study of Cu2+ and Zn2+ binding competition revealed that Cu2+ has the ability to dis-
place Zn2+ from the binding site, with a destabilizing effect (∆Tagg = 35
◦C). However,
for S100B ∆Cys, although Cu2+ also displaces Zn2+, it has the opposite effect stabilizing
the protein (∆Tagg = −5◦C). We observed that Cu2+, but not Zn2+ or Ca2+, has the
ability to promote intermolecular disulfide bond formation between S100B subunits.
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We hypothesize that metal induced conformational changes may account for the buildup
of conformers that have increased oligomerization propensity and that this may play a
role in S100B function and on its interactors. This possibility is particularly relevant
considering the interplay of S100B with the Amyloid-β peptide and with Receptor for
Advanced Glycation EndProducts, which are, all together, suggestive of an even more
interesting engagement of S100B in Alzheimer’s Disease.
Keywords - S100B, protein folding, metal ions, circular dichroism, thermal stability,
conformational changes
Resumo
As prote´ınas sa˜o macromole´culas altamente versa´teis que possuem inu´meras func¸o˜es na
ce´lula. No entanto, se tivermos em conta apenas a informac¸a˜o existente na sua cadeia
polipept´ıdica, estas na˜o sa˜o capazes de realizar todas as suas func¸o˜es, necessitando, por-
tanto, da ajuda de cofactores. Os io˜es meta´licos sa˜o importantes cofactores, estando
incorporados em mais de 30% das prote´ınas, desempenhando func¸o˜es catal´ıticas e es-
truturais. As propriedades qu´ımicas e de coordenac¸a˜o dos io˜es meta´licos permitem que
desempenhem importantes func¸o˜es ao n´ıvel da cata´lise enzima´tica, estabilizac¸a˜o proteica
e mediac¸a˜o da transduc¸a˜o de sinal. Para ale´m disso, os metais teˆm a capacidade na˜o
so´ de promover o folding correcto de uma prote´ına, como de induzir alterac¸o˜es confor-
macionais nesta. De facto, existem metaloprote´ınas que so´ conseguem adquirir o fold
correcto e, desta forma, possuir actividade biolo´gica, atrave´s da ligac¸a˜o de cofactores
meta´licos. No entanto, nem sempre os efeitos dos io˜es meta´licos sa˜o bene´ficos para os
sistemas vivos. Estes podem ser ta˜o essenciais como to´xicos e, por isso, as suas concen-
trac¸o˜es teˆm que ser altamente controladas. Pore´m, nem sempre esta regulac¸a˜o ocorre
levando a que, por vezes, estes io˜es se liguem a locais na˜o nativos, promovendo a agre-
gac¸a˜o proteica ou mediando ciclos redox que produzem espe´cies reactivas de oxige´nio ou
de azoto. Torna-se assim relevante o estudo e a caracterizac¸a˜o das func¸o˜es destes io˜es
meta´licos enquanto modeladores da conformac¸a˜o e estabilidade proteica.
Neste trabalho, pretendeu-se estudar o efeito que certos io˜es meta´licos teˆm na estabili-
dade e conformac¸a˜o de uma prote´ına, bem como a influeˆncia que a modulac¸a˜o por parte
dos metais tem na func¸a˜o proteica. O sistema modelo utilizado foi a famı´lia das pro-
te´ınas S100, em particular a prote´ına S100B. Sabe-se que a ligac¸a˜o de io˜es meta´licos a`s
prote´ınas S100 induz alterac¸o˜es conformacionais e que as mesmas esta˜o relacionadas com
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as func¸o˜es celulares destas prote´ınas. As prote´ınas S100 sa˜o, na sua maioria, homo- ou
heterod´ımeros de baixa massa molecular (10-12 kDa). Sa˜o exclusivamente expressas em
vertebrados e, ate´ a` data, existem 21 membros identificados. As S100 formam o maior
subgrupo pertencente a` superfamı´lia das prote´ınas EF-hand. Estas prote´ınas ligam Ca2+
a um motivo estrutural denominado EF-hand . Como ja´ foi referido, a ligac¸a˜o do Ca2+
induz uma alterac¸a˜o conformacional que expo˜e uma zona hidro´foba onde ocorre a ligac¸a˜o
de outras prote´ınas. Algumas prote´ınas S100 tambe´m teˆm a capacidade de ligar Cu2+ e
Zn2+ em locais que na˜o os de ligac¸a˜o ao Ca2+. Para ale´m disso, sa˜o altamente especial-
izadas, apresentando padro˜es de expressa˜o sub-celulares e em tecidos muito espec´ıficos.
Estas prote´ınas sa˜o componentes principais na rede de tamponizac¸a˜o e transduc¸a˜o de
sinal, regulando o ciclo, crescimento, diferenciac¸a˜o e mobilidade celulares.
A S100B e´ uma prote´ına que liga Ca2+, Cu2+ e Zn2+, sendo altamente expressa no
ce´rebro humano, possuindo diversas func¸o˜es intra e extracelulares. Esta prote´ına esta´
envolvida em va´rios processos patolo´gicos em que a homeostase dos metais esta´ alterada,
tais como a Doenc¸a de Alzheimer ou a Esclerose Lateral Amiotro´fica, o que representa
uma func¸a˜o proteica modificada. Embora se saiba que a ligac¸a˜o de io˜es meta´licos a`
prote´ına S100B induz mudanc¸as conformacionais, ainda permanecem por esclarecer os
mecanismos subjacentes a esta modulac¸a˜o e a forma como eles afectam a estabilidade
proteica. Neste trabalho, estudou-se exaustivamente o efeito que a ligac¸a˜o de io˜es meta´li-
cos tem no folding e na estabilidade da citocina S100B.
O ambiente fisiolo´gico em que a prote´ına se acumula, por exemplo a fenda sina´ptica, e´
rico em io˜es meta´licos. Desta forma, a interacc¸a˜o prote´ına-metal e´ relevante, na medida
em que pode ajudar a compreender o papel fisiolo´gico (e tambe´m patofisiolo´gico) da
S100B.
O principal transdutor das func¸o˜es extracelulares e´ o Receptor for Advanced Glycation
EndProducts (RAGE). Guenter Fritz , colaborador do laborato´rio de acolhimento onde
este trabalho foi realizado, observou recentemente que a interacc¸a˜o in vitro da prote´ına
S100B com o receptor RAGE e´ afectada por um cross-link espontaˆneo entre as duas
prote´ınas, atrave´s de uma ligac¸a˜o persulfureto. De forma a contornar este problema
produziu uma prote´ına mutada, a S100B ∆Cys, em que os dois res´ıduos de ciste´ına
(Cys84 e Cys68) foram substitu´ıdos por serinas. Esta mutac¸a˜o na˜o afectou a estrutura
global da prote´ına. No entanto, umas das he´lices ficou truncada e o C-terminal de-
struturado. Esta prote´ına mutada foi tambe´m objecto de estudo neste projecto, sendo
importante para se perceber o papel das ciste´ınas na conformac¸a˜o e estabilidade da
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prote´ına na sua forma selvagem.
Os io˜es meta´licos, tal como a prote´ına S100B, esta˜o envolvidos na doenc¸a de Alzheimer
(AD), nomeadamente na interacc¸a˜o com o pe´ptido Aβ. De facto, estes encontram-se
associados a`s placas de Aβ, uma caracter´ıstica eminente da AD. Estudos preliminares,
ainda na˜o publicados, que esta˜o a ser realizados no laborato´rio de acolhimento, revelaram
um efeito de cross-seed entre Aβ e a S100B. A amiloidoge´nese da prote´ına S100B ou do
pe´ptido e´ favorecida na presenc¸a de amilo´ides pre´-formados da outra prote´ına. Desta
forma, torna-se via´vel a possibilidade de envolvimento da prote´ına na agregac¸a˜o proteica
e neurodegenerac¸a˜o.
O estudo da conformac¸a˜o e estabilidade da prote´ına S100B foi realizado atrave´s do uso de
va´rios me´todos biof´ısicos de ana´lise de estabilidade proteica. As alterac¸o˜es estruturais
promovidas pela acc¸a˜o de io˜es meta´licos e a estabilidade te´rmica da prote´ına foram
estudadas Dicro´ısmo Circular (CD) de UV-long´ıquo.
Os resultados demonstram que tanto a ligac¸a˜o de Cu2+ como a de Zn2+, sa˜o responsa´veis
por modificac¸o˜es significativas na conformac¸a˜o proteica, originando alterac¸o˜es na estru-
tura secunda´ria e promovendo a agregac¸a˜o proteica. As experieˆncias de desnaturac¸a˜o
te´rmica realizadas indicam que tanto o Cu2+ como o Zn2+ sa˜o capazes de destabilizar a
prote´ına. De facto, no estado apo esta na˜o apresenta qualquer tipo de agregac¸a˜o prote-
ica, mesmo apo´s desnaturac¸a˜o te´rmica, mas quando se adiciona um destes metais, Cu2+
ou Zn2+ a Tagg=68
◦C e Tagg=65◦C, respectivamente. A destabilizac¸a˜o induzida por
estes metais leva a uma perda total da estrutura secunda´ria e a` agregac¸a˜o da prote´ına.
Por outro lado, a ligac¸a˜o de Ca2+ na˜o tem um efeito significativo na conformac¸a˜o e
estabilidade da prote´ına S100B. De facto, apo´s desnaturac¸a˜o te´rmica, os espectros de
CD revelam que a prote´ına apresenta uma mistura de estruturas secunda´rias: He´lices-α
e folhas-β. De referir que a prote´ına com Ca2+ ligado na˜o apresenta formac¸a˜o de agre-
gados. Os estudos de competic¸a˜o de ligac¸a˜o de metais, com ligac¸a˜o de Cu2+ e Zn2+,
indicam que o Cu2+ tem a capacidade de remover o Zn2+ do local de ligac¸a˜o, tendo um
efeito destabilizador (∆Tagg = 35
◦C). No entanto, para a prote´ına S100B ∆Cys, embora
o Cu2+ tambe´m seja capaz de remover o Zn2+, este apresenta um efeito oposto ao que se
via para a prote´ına wt. Neste caso, observa-se um efeito estabilizador (∆Tagg = −5◦C).
As experieˆncias realizadas com Ge´is PAGE ou SDS-PAGE na presenc¸a e auseˆncia do
agente redutor TCEP, permitiram afirmar que so´ o Cu2+, e na˜o o Zn2+ nem o Ca2+,
possui a capacidade de promover a formac¸a˜o de ligac¸o˜es persulfureto intermoleculares
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entre subunidades da prote´ına S100B.
Em conjunto, estes resultados permitiram-nos propor a hipo´tese de que as alterac¸o˜es
conformacionais induzidas pela ligac¸a˜o de metais podem explicar o aumento do nu´mero
de conformac¸o˜es que apresentam uma maior propensa˜o para a oligomerizac¸a˜o. Para
ale´m disto, esta ligac¸a˜o de io˜es meta´licos pode desempenhar um papel na func¸a˜o da
prote´ına e na sua interacc¸a˜o com outras mole´culas. Esta possibilidade e´ particularmente
relevante se tivermos em conta a interacc¸a˜o existente entre a prote´ına S100B, o pe´ptido
Aβ e o receptor RAGE. Estes treˆs intervenientes no poss´ıvel papel das prote´ınas S100 na
agregac¸a˜o proteica no espac¸o sina´ptico sugerem, em conjunto, uma ligac¸a˜o ainda mais
interessante entre a S100B e a AD.
Palavras-chave - S100B, folding de prote´ınas, io˜es meta´licos, dicro´ısmo circular, esta-
bilidade te´rmica, alterac¸o˜es conformacionais
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Chapter 1
Introduction
1.1 Metal Ions and Protein Folding
Metal ions are important cofactors in about 30% of all proteins, having catalytical and
structural roles essential to fulfill protein functions. They have unique chemistry and
coordination properties, which make them indispensable for living organisms. Moreover,
they have an impact in polypeptide properties influencing protein structure and stability.
Therefore, it is important to understand what are the effects of metal ions in proteins
and how do they influence protein strucuture and stability.
1.1.1 Metals in Biology
Metal ions are essential to life playing important roles in all classes of biological processes.
In fact, it is well-known that at least thirteen metals are indispensable for the survival
of plants and animals [1, 2]. Calcium, potassium, sodium and magnesium are the four
dominant metal ions in a cell, representing 1-2% of the human body weight. These are
known as bulk metals and have an important role in processes such as nerve conduction,
muscle contraction and stabilization of nucleic acids. However, not all of the essential
metals are so abundant as the ones mentioned above. The less abundant trace elements,
which represents only 0.01% of human body weight, include transition metals and are
essential nutrients to all forms of life. These transition metals are elements of the d-
block: vanadium, chromium, molybdenum, manganese, iron, cobalt, nickel, copper and
zinc [1, 3–5]. In Figure 1.1 is represented the periodic table of the elements showing
the position of metals that play important roles in biological systems [3].
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Figure 1.1: Biologically significant metals. Metal ions with biological roles are in
red; the black elements have some biologically relevant function. From ref. [6].
Metals can be both essential and toxic. If their concentration is not regulated they could
be harmful or even lethal to the organism. This toxicity appears, for example, through
the formation of reactive oxygen species that have the ability to damage several cellular
components including proteins, lipids and nucleic acids, which can lead to cell death.
In this way, nature has evolved with the purpose of regulate intracellular pools of metal
ions, in other words, in order to maintain a balance between metal ions as essential
elements and their potential toxic effect [1, 7].
Metal ions, in particular trace metals, have unique chemical and physical properties
which make them an integral and indispensable part of more than thirty percent of all
known proteins [1, 5]. In fact, they provide essential biochemical activities and are
structurally vital to several proteins [5]. Recent studies indicate that 47% of enzymes
require metals and that 41% contain metals in their catalytic center [2, 8] (Figure 1.2).
Although metal ions are natural constituents of proteins, they could also be found as
components of prosthetic groups, cofactors and several complexes before being inserted
into proteins [5].
The metal-binding proteins can be classified into several groups according to their func-
tions. They could act as enzymes or be electron carriers, being involved in metal or
oxygen management. Iron an copper are redox-active metals and participate in electron
transfer when they are bonded to metalloproteins such as cytochromes, iron-sulfur pro-
teins and blue-copper proteins, for example. Iron and copper are also involved in oxygen
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Figure 1.2: Metal ions involved in enzyme catalysis. The elements used as
cofactors by enzymes are shown in blue. The height of each column represents the
proportion of all enzymes with known structures using the respective metal. A single
enzyme uses cadmium. The elements in grey have no biological role. From ref. [8].
management (storage and carriage) via metalloproteins like myoglobin, hemoglobin or
hemocyanin. Enzymes like hydroxylases use magnesium, copper and zinc as cofactors.
Therefore, metals are involved in several biological processes spanning from protein stabi-
lization to enzyme catalysis and a wide variety of specific tasks essential to life processes
[1]. They are involved in signal transduction acting as molecular ”switches”, in nitro-
gen fixation, respiration and photosynthesis, function as redox centers and transporting
oxygen [9].
1.1.2 The Protein Folding Problem
Proteins are the most abundant and versatile macromolecules of the cell [10]. They play
a key role in a wide diversity of processes such as catalysis, signal transduction, ligand
binding and molecular interactions. In order to fulfill their biological activity, proteins
have to acquire their native three-dimensional strucuture. This structure is attained
through a process called protein folding. Protein folding is thus the physical process
by which a polypeptide folds into its characteristic and functional three-dimensional
structure [11].
This process has been under study for many years but it is not yet completely understood.
It is known, since pioneer Anfinsen’s work on ribonuclease [11] in the 1970’s, that
proteins can fold spontaneously without the intervention of additional entities. This
means that all information that is required to specify the three-dimensional structure of
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a protein is encoded solely in its primary structure. It was since Anfinsen’s experiments
that the thermodynamic hypothesis was born: this hypothesis postulates that if the
native structure of a protein is achieved spontaneously it should correspond to the most
stable conformation in a thermodynamic point of view [11].
Simultaneously, Levinthal focused on the kinetics and dynamics of the folding process
[12]. In his point of view, it did not make sense that the folding mechanism would
be a completely random sampling process resulting from the iteration of all possible
conformations since the conformational space to be explored would be too large. If
this would happen, a protein with 100 aminoacids would take 1029 years to fold, even
assuming that sampling of each conformation would be as fast as the time required for a
single molecule vibration (10−13 seg). This however, is inconsistent with the short time
scale (miliseconds to seconds) that a protein takes to fold [12]. This is known as the
Levinthal Paradox. According to this kinetic hypothesis, the folding of a polypeptide
occurs because there are energy barriers that force proteins to follow through specific
folding pathways, in which may occur intermediate states and at the end of which is the
native state. Nowadays, the majority of authors accept the theoretical formulation of the
energetic funnel to illustrate the mechanism of protein folding (Figure 1.3). According
to this point of view, there is no single pathway, but several possible ways of folding to be
followed in parallel by all the denatured polypeptide chains until they reach their native
state. The folding process can present multiple intermediates and the energy landscape
correspondent can display kinetic traps with high energy barriers. The external border
of the energy landscape is populated by the high energy denatured states that can flow
through the funnel by alternative pathways until they reach, the native conformation
[13].
It should be noted that the native state and the folded state of a protein are not syn-
onyms. The folded state of a protein is a compact three-dimensional structure floating
around a limited number of conformations. It implies secondary structure and several
weak interactions that have the ability to stabilize this compact state. On the other
hand, the native state is not necessarily correspondent to the folded state. In fact, it
corresponds to the biological active conformation but, for example, it can be a disor-
ganized state, without defined secondary structure. Usually, in these cases, the native
state acquire a defined structure when it is performing its biological function.
The unfolded state of a protein is an unstructured state without defined secondary,
tertiary or quaternary structure elements. This state can be induced in vitro by us-
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Figure 1.3: Three-dimensional representation of the folding funnel. From ref.
[14].
ing drastic conditions like high urea or guanidinium concentrations, high temperatures,
drastic pH values etc. The unfolded state can be seen as a mixture of several states that
can be interconverted.
Except for some special cases, the folded state is the most stable one. There are two
possible explanations for this stability: the thermodynamic and the kinetic hypothesis
[15].
In the thermodynamic hypothesis there are several factors contributing to the variation
of free energy in protein folding Figure 1.4. Some favor the folded state (internal in-
teractions and hydrophobic effect) and other favor the unfolded state (conformational
entropy) [17]. Conformational entropy concerns the global entropy of the polypeptide
chain and, because the folded state is much more organized than the unfolded one, this
entropic factor favors the unfolded state. However, the entropic component is counter
balanced by the hydrophobic effect, which favours internal organization and thus the
folded state. The origin of this entropic factor is on the unfavorable restrictions imposed
by the hydrophobic amino acids exposed to solvent. Finally, there is an enthalpic factor
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Figure 1.4: Stabilizing and destabilizing forces on the folding of a protein.
From ref. [16].
favoring the folded state which is the result of the sum of the internal covalent and
noncovalent interactions that stabilize the folded state: disulfide bridges, charge-charge
interactions, hydrogen bonding and van der Waals interactions [18]. The thermody-
namic hypothesis states that the folded state is thermodynamically more stable than
the unfolded one [19]. Moreover, it was already experimentally showed that the free
energy difference between the two states is small.
There is another possible explanation for protein stability which is the kinetic stability
hypothesis [15]. This hypothesis states that in case the unfolded state is thermodynam-
ically more stable than the folded one, there is a high energy barrier separating the two
states trapping proteins in the folded conformation.
Although protein folding is a fundamental process and the function of proteins depends
on it, sometimes this process does not occurs as expected. In fact, in the cellular en-
vironment, a fraction of all synthesized proteins fail to fold into the native structure
[20]. In order to deal with the challenges of the process of folding, biological systems
developed a specific protein machinery - the protein quality control (PQC) system -
that assists the folding process with no effect in the selection of the native structure
and in the degradation of incorrectly folded conformations. The PQC has the ability
to supervise folding, disable aggregation and remove misfolded or damaged polypeptide
chains before they exert toxic effects [21]. The system is composed by molecular chaper-
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ones, specialized intracellular proteases and accessory factors that regulate the activity
of chaperones and proteases or provide communication between the various components
[21]. However, the PQC systems sometimes fails and when this takes place brings se-
vere biological consequences that result for example in the so-called misfolding diseases
[22] or protein deposition in the form of insoluble amyloid fibrils. These amyloid fibrils
are characteristic of neurodegenerative disorders such as Alzheimer, Parkinson or prion
diseases [23–25].
Some proteins are only able to acquire its native structure in the presence of cofac-
tors such as metal ions. In fact, metal ions are key factors in the folding of several
metalloproteins.
1.1.3 Metal Ions in Protein Folding
Around 30% of human proteins contains a metal ion as a cofactor. In fact, metal ions
play an important role in protein folding and stability and despite the huge amount of
available information about the structure of several metalloproteins, this role is complex
and remains mostly unknown. In order to understand this relationship we need to
address how metals bind to proteins: before, during or after protein folding. It is also
important to understand how a protein selects a specific metal from the pool of metal
ions that are present in the cellular environment.
There are several possible scenarios that can be outlined for the folding of metallo-
proteins (Figure 1.5). The metal insertion into different metalloproteins is likely to
occur at different moments of the protein biogenesis process. Metal ions may bind to
a protein during translation, i.e, as the polypeptide chain emerges from the ribosome,
after polypeptide release but before it is completely folded or after polypetide acquire
its folded conformation.
Metals may induce protein folding or protein conformational changes. Proteins emerge
from the ribosome in the unfolded or partially folded state and metal insertion may be
necessary for folding. Some newly synthesized apo proteins (metal-free) are not able
to acquire its folded state until metal insertion. Zinc finger domains are an example
of this since they can only fold to the native structure in the presence of zinc. There
are some cases in which metal ions bind to the nascent polypeptide chain as it emerges
from the ribosome. For example, we can enumerate iron, from heme, that binds to
unfolded state of cytochrome b562 and copper, which remains bounded to azurin even
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Figure 1.5: Distinct pathways for metalloproteins folding. Metal insertion into
different metalloproteins is likely to occur at different steps of protein biogenesis process.
From ref. [1].
after unfolding of the protein. Some metalloproteins, like most calcium-binding proteins
(e.g. S100 proteins), are able to acquire its folded structure without metal binding.
In these cases metal incorporation is necessary for conformational changes or to fulfill
catalytical functions. These calcium binding proteins remain in the folded state even
if metal is released from the holo (metal-bound) state. However, for other proteins,
metal release can result in either misfolding or unfolding as a result of conformational
destabilization [1].
The next sections briefly describe the interplay between metal ions and protein folding,
focusing in the most relevant metal ions — iron, zinc, copper and calcium.
Iron
Iron is the transition metal most abundant in the human body. It has oxidation states
ranging from −2 to +6 but the two most biologically relevant are Fe2+ and Fe3+ [5].
These two stable oxidation states make iron a very versatile element which renders this
metal an important redox mediator. In proteins, it is found in an unparalleled variety of
sites and cofactors, including, for instance, Fe-O-Fe sites, heme groups and iron-sulfur
clusters [26]. Incorporation of iron into proteins may take place in three different ways:
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Figure 1.6: Fe3+-induced conformational changes in human transferrin. The
apo form (1BP5, left) has an open conformation. When Fe3+ binds, the holo protein
(1A8F, right) adopts a different conformation. The two protein domains close around
the inter-domain hinge enclosing the metal ion in the protein core[6]. Image rendered
using PyMOL software [27].
in the form of a heme prosthetic group, in iron sulfur clusters or by the bound of iron
into non-heme iron proteins.
Iron has an important role in iron-proteins folding. One of the best studied cases resulting
from this interplay is the folding of cytochrome c. In this protein the iron is inserted
in a heme group which is covalently bound to the polypetide. It has been shown that
the substitution of the metal ion (Fe3+) in the heme group is associated with important
consequences in the protein folding [28–30]. Moreover, the removal of the heme group
leads to secondary and tertiary structure loss [31]. Although this suggests that heme is
necessary for cytochrome folding there are other evidences that may suggest otherwise.
It was observed a spontaneous folding of apo cytochrome c555 from aquifex aeolicus [32].
Furthermore, apo cytochrome c551 from Pseudomonas aeruginosa unfolds reversibly and
acquires a compact marginally stable conformation [33]. Another example is transferrin
that undergoes conformational changes after iron binding, which stabilizes the protein
and alters the unfolding pathway of it [34] (Figure 1.6).
Zinc
Zinc is essential to all forms of life and is the second most abundant transition metal in
several organisms, including humans [35]. This metal is also the second most abundant
metal ion in enzymes participating in at least 300 enzymatic reactions [2, 36]. Zinc is a
redox inert metal ion which make it a generally considered less toxic than redox active
metals such as iron and copper [5].
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Figure 1.7: Folding of a zinc finger domain. Structure of a zinc finger domain
(2CT5, right). This domain only acquires the secondary structure upon zinc binding.
In the absence of zinc the domain is completely unstructured (left).
As mentioned before, zinc is an important cofactor in catalysis since it has a rapid ligand
exchange rate that allows an efficient turnover of reaction products [37]. Although zinc
is a redox inactive-metal ion it is necessary to maintain the proper structure and function
of several proteins [36]. Incorporation of zinc in a variety of biological systems is due to
its structural and thermodynamic properties and also with the abundant bioavailability
of this metal.
The folding of several proteins is dependent of zinc ions, in particular proteins containing
zinc finger domains. Zinc fingers are the most abundant structural domain in the human
proteome (present in 3% of all proteins) and they are also the most prevalent zinc binding
motif [38, 39]. The classic structure of zinc finger domains has a ββα fold where zinc ion
binds. The topology of the domain is kept in place by zinc ion, which is strictly required
as an essential structural determinant (Figure 1.7). In fact, if the coordinating residues
are removed, the fold is disrupted [1]. Moreover, the apo form of zinc finger domains
is unstructured and acquires only the proper fold upon zinc binding. Furthermore, the
zinc-bound domain is stabilized and becomes competent in DNA binding [40].
Other proteins like Cu, Zn-superoxide dismutase (Cu, Zn-SOD1) require zinc as cofactor.
Although zinc does not take part of the catalysis it is crucial for the protein folding and
thermostability [41].
Yeast alcohol dehydrogenase requires two zinc ions per subunit, one sits in the catalytic
site and the other has a structural role. In this case it has been described that zinc is
essential for protein proper folding, confering a higher chemical stability and a higher
folding cooperativity [42–44].
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Copper
Copper is a crucial transition metal in biology as it plays a key role in all living organisms,
being essential to many forms of life. In biological systems it can be found predominantly
in two oxidation states Cu1+ and Cu2+. Cu2+ is the most effective bioavailable divalent
cation for binding organic molecules as is Cu1+ for monovalent cations, due to electron
affinity. It has an important role in cellular redox reactions, being indispensable for
the catalysis and structure of a wide range of enzymes whose activities are essential for
several and important biochemical and regulatory processes [5].
Like other metal ions copper is necessary for the proper fold of some proteins. It is a
cofactor for proteins involved in electron tranfer, oxidase and oxygenase activities, acting
as a biological activity centre for proteins like Cu, Zn-SOD, ceruloplasmin, cytochrome
c oxidase, tyrosinase and dopamine β-hydroxylase [45].
Pseudomonas aeruginosa azurin is a blue-copper protein that contains a single copper
ion. The apo and the holo form of this protein have a three-dimensional structure
identical. However, this metal ion have a significant effect in azurin’s thermodynamic
stability. In fact, it was reported that copper oxidized is more thermodinamically stable
than the reduced copper form. Moreover, the holo form is more stable than apo-azurin
[46]. The stability of apo protein is 6.9 kcal.mol−1 but after the binding of Cu2+ it raises
to 12.4 kcal.mol−1. It was proposed that the mechanism by which copper increases azurin
thermodynamic stability is based only on slower unfolding, as it was observed that holo-
azurin unfolds much slower than apo-azurin. The metal ion binds the native and the
unfolded state of azurin which is important for folding kinetics. If Cu2+ binds before
folding it accelarates the kinetics (miliseconds) relatively to copper binding after apo
protein folding is complete (minutes to hours) [47] (Figure 1.8).
Copper is also required for the stability of ceruloplasmin. This protein binds six copper
ions and like azurin, holo protein is more stable than apo-ceruloplasmin (Tm increases
from 15 to 25◦C) [48].
Calcium
Calcium is an ubiquitous second messenger that can transduce extracellular signals into
several intracellular responses. Thereby it can regulate many biological processes such as
muscle contraction, neurotransmitter release, fertilization and cell growth [49]. Diverse
enzymes activities are also controled by calcium ions [50]. Due to its pivotal role, the
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Figure 1.8: Formation of active Cu-Azurin. Cu2+binding to Azurin before or after
folding is an important factor in folding kinetics of this protein. From ref. [47].
Figure 1.9: Calcium-dependent conformational change in S100 proteins.
Three-dimensional structures of Apo S100A11 (left) and Ca2+-bound S100A11(right).
As could be seen in the figure, Ca2+-binding induces a conformational change in the
structure of S100A11. From ref. [49].
cellular machinery maintain tigh control of this ion concentration,which ranges from
resting levels near 100 nM to signalling levels near 1 µM [49]. Calcium ions control
a wide variety of cellular events in part via interaction with a large number of Ca2+
binding proteins [50].
The most abundant calcium binding motif is the helix-loop-helix EF-hand, present in
several proteins, including S100 proteins, calmodulin and troponin C. Some EF-hand
proteins undergo a substantial conformational change upon Ca2+ binding that results
from the lateral motions of the two helices that flank the Ca2+ binding residues[1].
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This conformational change exposes a hydrophobic surface necessary for protein-protein
interactions (Figure 1.9).
Calmodulin, a well studied EF-hand protein, regulates enzyme activities, neurotrans-
miter release, cell proliferation and DNA repair. The majority of these activities require
interaction with other proteins which is dependent of calcium binding [6].
Calcium has an important role in the folding of parvalbumin. The apo-parvalbumin has
been described as natively disordered [51]. In the calcium-bound state the protein rests
in a compact globular state, with the EF-hand in an open state. However, after metal
ion release occurs a fast (∼60 ps) conformational rearragement that leads to a decrease
in helical content (>20%) and to an enhanced residue solvent accessibility [52].
Another example of calcium-dependent conformational changes in EF-hand proteins
relies on bovine α-lactalbumin. This protein is able to regulate lactose synthesis in a
calcium-binding dependent manner. Calcium increases its folding rate by three orders
of magnitude [53–55] and couples refolding to the generation of the native disulfide
bridge [56]. All together these facts suggest that occurs a calcium regulation of lactose
synthesis through the control of protein folding. Moreover, it is known that calcium
accelerates the folding of α-lactalbumin by decreasing the energy barrier between the
molten globule and the transition state [55].
1.2 S100 Proteins
Metal ion binding to S100 proteins are associated with conformational readjustments
that underlie the cellular functions of these proteins. In this project the protein model
system used was S100 protein family, in particular the S100B protein.
1.2.1 The Family of S100 Proteins
The name of the S100 protein family is due to the fact that the first identified S100s
were obtained from the soluble(S) bovine brain fraction upon fractionation with 100%
saturated solution of ammonium sulfate [57].
This protein family represents the largest subgroup within the superfamily of EF-hand
Ca2+ binding proteins [3, 49, 58]. The family of EF-hand proteins can be divided
into two primary classes: Ca2+ sensors, which transduce the Ca2+ signals, and Ca2+
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signal modulators, which are involved in uptake, transport and buffering of the Ca2+
signal. The majority of the members of the S100 protein family are Ca2+ sensors. Only
S100G acts as a Ca2+ buffer sequestering Ca2+ in the cytoplasm after a raise in metal
concentration [59].
S100 proteins are exclusively expressed in vertebrates. This family comprisis 21 mem-
bers identified up to date in humans. Furthermore similar numbers are found in other
mammalia based on genomic analysis. Other diverse branches of S100 proteins were
found in other vertebrates [58].
Each member of S100 protein family is encoded by a separate gene which are mostly
clustered in region 1q21 of human chromosome 1 [60, 61]. The human S100 proteins have
a gene structure highly conserved, in general comprising three exons and two introns [59].
This region contains the genes from S100A1 to S100A16. The genes of other members
of the family like S100B, S100P or S100Z are found, respectively, in chromosomes 21, 4
and 5 [58]. It should be noted that the level of sequence identity among these proteins
within one species varies. For human proteins the identity ranges between 22% and 57%
[62].
S100 proteins have cell- and tissue-specific expression patterns as well as specific sub-
cellular localization, pointing towards a high degree of specialization [3, 58]. This level
of specialization has meant that the S100 proteins are involved in several cellular pro-
cesses such as cell cycle regulation, growth, differentiation and motility [59]. Due to
these multitude of functions it is quite normal to find that these proteins are implicated
in several human diseases, like different types of cancer, with altered expression levels
of S100 proteins, inflammatory and autoimmune diseases [63] and neurodegenerative
disorders, such as Alzheimer’s Disease (AD) [64].
Metal ions have the ability to modulate the conformational properties and functions of
S100 proteins. As mentioned in section 1.1.3 the binding of Ca2+ to proteins with EF-
hand domains triggers conformational changes that are necessary to the interaction with
other proteins (see section 1.3.3). In the case of S100G, the Ca2+-induced conformational
change is small and does not lead to the exposure of a hydrophobic patch [59].
Zn2+ binding have also a role in folding and function of many S100 proteins. Further-
more, the Receptor for Advanced Glycation Endproducts (RAGE) has been identified
as a new target for several S100 proteins. Several reports showed that an increasing
number of S100 proteins are bonded extracellularly to RAGE [65–68] or to Toll-like
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receptor 4 [69].
1.2.2 Structural properties
S100 protein family members are acidic proteins with a molecular mass that ranges be-
tween 10-12 kDa. These proteins have the ability to form homodimers, heterodimers and
even oligomers but with largely different preferences. This fact, in particular the forma-
tion of heterodimers, may contribute to S100 functional diversification [59]. Almost all
S100 proteins exist as dimers at physiological conditions. The exception is S100G, which
exists as a monomer. However, in a general way, these dimers are linked non covalently
and, therefore, it is observed a monomer-dimer equilibrium. This equilibrium is strongly
dependent on the ionic strength of the solution. It has been reported that at higher ionic
strengths S100B protein, for example, exists predominantly as a homodimer. In contrast,
lowering the ionic strength results in a higher formation of monomeric protein [70]. It
was also shown that other S100 proteins might exist as monomers at very low protein
concentration in the cell. The physiological function of these monomers is not known
yet. It was proposed that the equilibrium between monomers and homodimers might
facilitate the formation of heterodimers in the cell. The list of known S100 heterodimers
is becoming larger. Until now it is known that S100B protein forms heterodimers with
S100A1, S100A6 and S100A11; S100A1 with S100A4 and S100P; and S100A7 with
S100A10. Moreover, non-covalent multimers were observed for S100A12, S100A8/A9,
S100B, S100A4. It was also observed a Zn2+-dependent tetramer for S100A12. The
formation of S100A8/A9 heterodimers is more favorable than the formation of S100A8
and S100A9 homodimers. In fact, if we compared the structure of the heterodimer with
the structure of the corresponding homodimers we can observe that the solvent exposed
area is reduced in the heterodimer, which can be the driving force for its formation [58].
EF-hand Ca2+-binding
The name EF-hand was first used by Kretesinger and Nockolds in 1973 and is a graphical
description of the calcium-binding motif observed in parvalbumin [71].
This structural motif became very widespread, found in a large number of protein families
[74]. In fact, the EF-hand motif is one of the most common in animal cells [75]. S100
proteins belong to the Ca2+-binding EF-hand motif superfamily [63]. These proteins
present some variation in their sequence but despite that, their tridimensional structure
exhibit highly conserved key structural features and common to all members of the
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Figure 1.10: Structure of S100 proteins. (A-B) Ca2+-driven conformational
changes at the EF-hand in S100 proteins. Structure of the N-terminal, S100-specific
EF-hand (A) and the C-terminal, canonical EF-hand (B) in the metalfree (white) and
Ca2+-bound (green) form of S100A6. (C-D) Structure of the human S100B homodimer
loaded with Ca2+ and Zn2+ [72]. (C) Side view; (D) Top view.
(a) a (b) b (c) c
Figure 1.11: Ca2+ binding sites of S100A6 protein. a) Ca2+-free S100-specific EF-
hand b) Ca2+-loaded S100-specific EF-hand c) Ca2+-loaded canonical EF-hand. Image
rendered using PyMOL software [27] (PDB codes 1K8U, 1K96)[73].
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family. Each S100 monomer is composed by two EF-hand helix-loop-helix structural
motifs arranged in a back-to-back manner and connected by a flexible linker (Figure
1.10B). The C-terminal EF-hand contains the classical Ca2+-binding motif, common
to all EF-hand proteins. The Ca2+-binding loop has a typical sequence signature of 12
aminoacids and is flanked by two helices: HIII and HIV. Ca
2+ is coordinated mainly by
amino acid side chains. The N-terminal EF-hand has a different architecture distict from
the canonical EF-hand motif. Here, Ca2+ is mainly coordinated by backbone carbonyls.
It contains 14 specific aminoacids motif, a consensus-sequence motif, flanked by helix
HI and HII (Figure 1.10A). As this motif is characteristic of S100 proteins it is called
the ’S100-specific’ or ’pseudo EF-hand’. In both EF-hands Ca2+ is coordinated in a
pentagonal bipyramidal geometry. There are six residues involved in the binding: X, Y,
Z, -X, -Y, and -Z [59, 76] (Figure 1.11). All of them are ligands except the residue
-X that is occupied by a water molecule. At position -Z there are a glutamate or an
aspartate residue which makes possible the binding to Ca2+ in a bidentate coordination
manner, since it provides a carboxylate group for the binding to the metal ion. The
interface of S100 homodimer is formed by helix HI of the N-terminal and helix HIV of
the C-terminal, from both monomers (Figure 1.10C-D). The helices build a compact
and stable four helix bundle [59]. S100 proteins bind usually four Ca2+ ions per dimer
with a Kd=20-500 µM and with strong positive cooperativity [77].
Zn2+-binding sites
Unlike other EF-hand proteins, many S100 proteins have the ability to bind Zn2+ with
high affinity (Kd=4 nM to 2 mM) [78]. This occur in binding sites distinct from the
EF-hand Ca2+-binding sites. Moreover, in some cases, it has been proposed that Zn2+
instead of Ca2+ regulates the biological function [59]. In fact, it has been reported that
the interaction between S100B and tau protein is Ca2+-independent but Zn2+-dependent
[59]. However, most of the reported Zn2+ constants are in the µM range, which stands
in contrast with the low nM concentrations of free Zn2+ (2 to 10 nM) in cytoplasm. Due
to this low concentration, the binding of Zn2+ to the majority of S100 proteins does
not occur in the cytoplasm, being S100B and S100A6 two examples [59]. Zn2+-binding
might occur in vesicles that contain a higher concentration of this metal (µM to mM),
or in the extracellular space, which has Zn2+ concentrations in the µM range [59].
S100 proteins have the ability to bind Zn2+ in two different ways and because of that they
can be divided into two groups. The first one involves Cys residues in Zn2+ coordination
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Figure 1.12: Structural difference between a Cys and a Ser residue.
and the second group binds Zn2+ exclusively via the side-chains of His, Glu and Asp
residues [58]. An example of the first group is S100A2, in which Zn2+ is coordinated
by residues from different monomers [79]. S100A7, S100A8/A9, S100A12 and S100B
are members of the second group and it is available detailed structural information,
mainly by X-ray, about them. S100A7, S100A12 and S100B can bind two Zn2+ ions per
homodimer at dimer interface. The dimer is additionally stabilized because the Zn2+
ions are coordinated by residues from both subunits [80–82].
Cu2+-binding sites
A number of S100 proteins also bind Cu2+. This is the case of S100A5 [83], S100A12
[84], S100A13 [85] and S100B [86]. The binding of copper frequently occurs at the same
sites to which Zn2+ binds but with different affinities (Kd=0.46-55 µM) [83, 86, 87].
S100B, one of the most abundant protein in the human brain, also binds Cu2+. It has
been sugested that Cu2+-binding to this protein might have a putative neuroprotective
role. Bovine S100B can efficiently sequester copper ions and hereby supress copper-ion-
induced cell damage [59, 86].
1.3 S100B Cytokine
S100B, a 10.7 kDa protein, is a member of S100 protein family. It was originally dis-
covered in glial cells, being the first described protein of the family [57]. It is highly
expressed in astrocytes and is one of the most abundant soluble proteins in human brain,
constituting 0.5% of them [72]. S100B functions as both an intracellular Ca2+ receptor
and an extracellular neuropeptide [88–90]. The binding of Ca2+ to S100B protein have
important functional implications. The main transducer of extracellular functions of
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Figure 1.13: Structural alignment of S100B wt and S100B ∆Cys. S100B wt
and S100B ∆Cys are represented in orange and grey, respectively. Image rendered using
PyMOL software [27].
this protein is RAGE (section 1.3.3). In vitro, S100B-RAGE interaction is affected by
the spontaneous cross-link between the two proteins through a disulfide bond. In order
to circumvent this problem, Fritz et al produced a S100B ∆Cys protein. This protein is
a Cys to Serine(Ser) mutant of S100B wt protein. The two mutated residues of S100B
∆Cys, Cys68 and Cys84, are near C-terminal. This is an appropriate replacement since
the diference between Cys and Ser is only in one atom (Figure 1.12).
The mutation does not affect the overall structure of the protein. However, as we can see
in S100B wt and S100B ∆Cys structural alignment (Figure 1.13) the helix HIV, where
Zn2+ binds is truncated and the C-terminal is unstructured. After co-crystallization
trials it was observed that the C-terminal where Cys84 is located got disordered upon
mutation to Ser. Usually the C-terminal becomes even more ordered upon Ca2+ binding,
which not occur with the mutant. Moreover, several Phenylalanine residues in the C-
terminal are required for target binding which are disordered in the mutant protein.
The data related to S100B ∆Cys protein were supplied by Fritz and Betz (unpublished
observations in the scope of an ongoing collaboration with our Protein Biochemistry Fold-
ing and Stability group - http://www.uniklinik-freiburg.de/neuropathologie/live/forschung/ag-
g-fritz.html?raw=true).
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1.3.1 Structure and Metal Binding Properties
S100B protein has a structure typical of S100 protein family (see section 1.2.2) (image
S100B structure). The three-dimensional structures of S100B, solved by NMR and
crystallography, are reported for the calcium-free state [91, 92], calcium bond state [67,
93–95], with both Ca2+ and Zn2+ bond [96] as well as in the presence of target protein
derived peptides (p53 [97], Ndr-kinase [98], capZ [99]). In all of these structures, S100B
is displayed as a homodimer with an affinity so high (KD in picomolar range or lower)
that under all biological circumstances the monomers are absent [100]. Although S100B
is mainly found as a homodimer, active tetramers and hexamers have been reported [67].
The N-terminal EF-hand of this protein suffers only minor conformational changes upon
Ca2+ binding. However, the C-terminal EF-hand exhibits a significant structural change
that exposes hydrophobic surfaces that allows the interaction with other proteins [59,
101]. The change of conformation in this C-terminal domain correlates a 90◦ change in
angle between helix HIII and HIV upon Ca
2+binding [102].
S100B binds four calcium ions per dimer with moderate affinity (Kd 2-20 µM). In phys-
iological ionic strength this protein binds also four Zn2+ ions with high affinity (Kd
0.1-1 µM). Tne Zn2+ sites are six to eight [77, 103]. The affinity of Ca2+ for S100B
increases about 10-fold in the presence of Zn2+ [103]. Moreover, S100B also binds four
copper ions per homodimer with sub-micromolar affinity (Kd =0.46 µM) [59]. It has
been suggested that this protein plays a role against copper induced oxidative stress in
cells, having a neuroprotective function [86]. It should be noted that zinc and copper
are two metal ions highly abundant in senile plaques [59, 101, 102, 104].
1.3.2 Cellular functions
S100B protein, like S100 protein family, possess several intra- and extracelullar roles Fig-
ure 1.14. In terms of intracellular functions S100B protein interacts with cytoskeleton
through the modulation of microtubule assembly in a Ca2+- and pH-dependent man-
ner. It has also an important role in cell proliferation and survival, since its levels are
elevated in certain tumor cells and in astrogliosis. This protein can also inhibit cell
differentiation and is involved in the regulation of several enzymes. These functions are
all Ca2+-dependent. Moreover, regulation of Ca2+ homeostasis in astrocytes is another
important intracellular function of S100B protein [105].
S100B is secreted from glial cells to the extracellular space upon changes in intracellular
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Figure 1.14: Intra- and extracellular functions of S100 proteins S100 proteins
act as Ca2+sensor proteins in the cell and transmit a signal by Ca2+-dependent binding
to a target protein, regulating its biological activity. Furthermore, several S100 proteins
are secreted upon a Ca2+signal. Extracellularly in the presence of high concentrations of
Ca2+and Zn2+, S100 proteins can form polymers and bind to the receptor RAGE. From
ref. [62]
Zn2+ and Ca2+ concentrations by vesicular transport. In the extracellular space it ex-
hibits cytokine-like functions [106]. The extracellular action of this protein is strongly
dependent on its concentration; at nM levels it exhibits a neuroprotective role, promoting
neuronal survival and stimulating neurite growth but at µM concentration it promotes
neuronal apoptosis, leading to the induction of pro-inflammatory cytokines and inflam-
matory stress-related enzymes [104, 107–111]. The extracellular regulatory activities
of S100B have an effect on neurons, astrocytes, microglia, monocytes, macrophages,
myoblasts and in other cells [105].
High extracellular levels of S100B protein are associated with several neurological dis-
orders including AD, multiple sclerosis, amyotrophic lateral sclerosis, schizophrenia,
epilepsy,hypoxia and traumatic brain injury [88–90, 112, 113]. Extracellular S100B
exerts dose dependent neurotrophic and neurotoxic action and both effects are mediated
in the brain by RAGE (section 1.3.3) [107, 114, 115].
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1.3.3 S100B Protein Interactors
p53
p53, a tumor supressor protein, is a homotetrameric transcription factor that regulates
several cellular processes. It has a crucial role in the control of cancer being respon-
sible for preventing tumorigenic transformation in response to stress. This control is
performed through the induction of cell cycle arrest or apoptosis [116].
Calcium binding induces a conformational change in S100B structure which destabi-
lizes the protein quaternary structure and allows the interaction with other proteins,
in particular with p53 [116]. There are some doubts regarding the role of S100B in
p53 function. However, there are reports suggesting that this protein binds directly to
the p53 tumor suppressor protein in melanoma [117–120], reduces p53 protein levels
[120, 121], and inhibits wild-type p53 functions in malignant melanoma [120–122].
The data presented in [123] suggests that the high levels of S100B protein found in ma-
lignant melanoma may contribute to the down-regulation of the p53 tumor suppressor
via a direct S100B-p53 interaction [122]. This interaction may occur by S100B desta-
bilizing p53 and/or preventing the formation of p53 oligomers, as previously observed
[116, 117, 124, 125].
RAGE
The Receptor for Advanced Glycation Endproducts (RAGE) has been firstly described
in 1992. Since then its involvement in several diseases has been extensively studied which
resulted in a growing interest in RAGE as a therapeutic target [66]. Despite this receptor
is not essential to life [66] it has an important role in human pathologies including
diabetes, tumour outgrowth, chronic inflammation and neurodenerative disorders like
Alzheimer’s disease or multiple sclerosis [66]. In fact, RAGE signaling is very important
in the inflammatory response [107], mediating aspects of innate immunity [126], acute
and chronic inflammation [127] and certain cancers [128]. RAGE is up-regulated in
these diseases [129].
RAGE is a member of the immunoglobulin (Ig) superfamily of cell surface receptors shar-
ing structural homology with other Ig like receptors [66]. It consists of an extracellular
moiety, a single transmembrane spanning helix and a short cytosolic domain which is re-
quired for signal transduction. The extracellular moiety includes one N-terminal V-type
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and two C-type Ig domains [67]. Additional RAGE isoforms lacking the transmembrane
and the cytosolic regions (soluble RAGE (sRAGE) for example) were identified in human
brain which suggests isoform-specific functions for the receptor [130].
RAGE has the ability to mediate physiological and pathological effects through inter-
action with several ligands, each of them associated with a specific disease. Recently
RAGE has been identified as a new target for several S100 proteins, including S100B
[104].
S100B protects neurons against neurotoxic agents by interacting with RAGE. It is known
that, at relatively high concentrations, S100B is neurotoxic causing neuronal death
via excessive stimulation of RAGE [131]. S100B modulate cell survival in a RAGE-
dependent manner, interacting specifically with V and C1 domains of the receptor [132].
It is also known that both trophic and toxic effects of extracellular S100B are mediated
in the brain by the RAGE receptor [105].
1.3.4 S100B and Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common form of dementia. It is characterized by
the presence of deposits of amyloid-β (Aβ) peptide located extracellularly and neurofib-
rillary tangles, an altered intracellular arrangement of hyperphosphorylated polyubiqui-
tinated tau protein [133, 134]. Metal ions, in particular zinc, iron, calcium and copper,
are essential for neuronal activities and have an important role in AD. Aβ binds different
metal ions, which influence its structure and amyloidogenic properties [135, 136].
AD has been the most extensively studied neurodegenerative disease regarding S100B
pathology [137]. Several studies revealed that S100B protein is present in elevated levels
in the brain and cerebrospinal fuid of AD patients [104].
In transgenic mice overexpressing S100B it was observed an enhanced susceptibility to
neuroinflammation and neuronal dysfunction after infusion of Aβ. These observations
support a role for S100B in AD. Moreover, recent studies in double transgenic mice over-
expressing S100B and carrying a mutation in Amyloid precursor protein (APP), showed
that S100B overexpression promotes brain inflammation and enhances Aβ generation
from APP [104].
S100B might also have an important role in the formation of neurofibrillar tangles.
Intracellular neurofibrillary tangles are mainly composed of hyperphosphorylated tau
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Figure 1.15: Multimeric states of S100 proteins. S100B octamer (2H61), S100A12
hexamer (1GQM), S100A8/A9 tetramer (1XK4). Image rendered using PyMOL software
[27].
protein. S100B binds directly to tau protein in a Ca2+-dependent manner. This binding
results in inhibition of tau phosphorylation [104]. However, extracellular S100B promote
RAGE-dependent hyperphosphorylation of tau protein [104].
These observations suggest that S100B exhibits opposite effects depending on its local-
ization. S100B has the ability to promote the hyperphosphorylation of tau protein and
has also an important role in the development of neurofibrilary tangles. These S100B
capabilities are mediated by RAGE [104].
So, regarding all of these observations, it was hypothesized that the role of S100B in AD
is mediated by RAGE [104].
Recent data support a novel strategy that uses S100B inhibition for reducing cortical
plaque load, gliosis and neuronal dysfunction in AD. Moreover, the results obtained by
Roltsch and coworkers suggest that both extracellular and intracellular S100B contribute
to AD histopathology [138].
It is well stablished that metals like Ca2+, Cu2+ and Zn2+ are present in the synap-
tic cleft in high concentrations [139]. As mentioned above they are also involved in
AD, being part of Aβ plaques. These metals play a crucial role in the formation of
larger oligomeric species of S100 proteins, namely tetramers, hexamers and octamers
Figure 1.15. The formation of these oligomeric species are, in several cases, essential
for biological function and signaling. S100B protein, for example, binds RAGE in the
tetrameric form with higher affinity than in the dimer state. Moreover, the presence
of Ca2+ promotes the oligomerization of S100B into hexamers and octamers. Ca2+ is
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Figure 1.16: Possible involvement of S100 proteins in synaptic protein ag-
gregation in neurodegeneration.
also responsible for the formation of the S100A8/A9 tetramer, essential to microtubule
formation. Zn2+ has also a role in oligomerization, promoting the formation of S100A2
tetramer. Apparently metal ions have an importante role in the formation of functional
S100 oligomer. Recently, it has been discovered a new property of some S100 proteins
and a new role emerge: S100A8/A9 proteins can form amyloids in a metal ion mediated
fibrillation process in the ageing prostate [140].
Several experiments performed in the host laboratory revealed a new interaction between
S100B and Aβ peptide. These preliminary unpublished results showed a cross-seed effect
between S100B and the Aβ peptide. S100B or Aβ amiloidogenesis is enhanced in the
presence of pre-formed amyloids of the other protein.
Metallothionein-3 is an intra- an extracellular metalloprotein that is highly expressed
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in the brain and downregulated in AD. This protein has the ability to protect, by an
unknown mechanism, neurons from the toxicity that Aβ promotes. This toxicity is
related with Cu2+ and Zn2+ interactions with this peptide. It has been reported that a
metal swap between the metalloprotein and Aβ-Cu2+ abolishes the production of ROS
and the related cellular toxicity [141]. This protective effect could be an important
step in AD treatment, leading to new therapeutic strategies. S100B protein and this
metallothionein are both expressed in the brain. The Cu2+-binding to S100B have a
putative neuroprotective role as described previously. These facts suggest that there are
some similarities between the two proteins that can be exploited.
1.4 Objectives
Metal ions, in particular Ca2+, Cu2+ and Zn2+, have an important role in the regulation
and, therefore, in the function of S100B protein. Although this role is well documented,
their consequences in protein stability are not known. This fact is particularly impor-
tant since S100B protein is involved in several pathological processes in which metal
homeostasis is imbalanced leading to a modified protein function. This project aims to
investigate the effect of metal ions on conformation and stability of protein S100B, which
is essential in modulation of protein-protein interactions. Moreover, it intends to clarify
the metal-dependent mechanisms by which the modulation of activity and structure of
S100B protein occurs.
With this purpose were studied the wt form of human S100B as well as a mutated
variant, S100B ∆Cys. S100B ∆Cys protein exposes less efficiently the hydrophobic core
in response to binding of Ca2+, which results in a weak interaction. This protein is also
an important control for Zn2+ binding.
Chapter 2
Methodologies and Procedures
2.1 Biophysical methods to monitor protein
conformational stability
The structure of a native protein is characterized by a set of unique spectral proper-
ties. During denaturation or protein conformational changes these properties undergo
alterations. Therefore, they can be used to evaluate and monitor the denaturation pro-
cess, by the action of chemical or physical agents. So, it is possible to monitor protein
conformation and stability following the action of several destabilizing factors.
A diversity of biophysical methods are available to monitor and study the different
components and characteristics of protein structure. The experimental techniques, the
time scale that can be monitored and the information that can be extracted from each
technique has been recently overviewed in an excellent review and is summarized in
Table 2.1.
From the experimental data obtained by the different techniques it is possible to draw
curves similar to the one represented in Figure 2.1, from which thermodynamic pa-
rameters of the reaction can be obtained. The midpoint transition determined from the
curves, such as temperature (Tm) or concentration of chemical denaturant (Cm), is used
for comparing protein stability.
The following sections will address biophysical methods used in this work to monitor
protein conformation and stability .
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Table 2.1: Experimental techniques useful for protein folding study. From ref.
[142].
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Figure 2.1: Representation of a hypothetical denaturation curve. The cartoons
represent the native state (bottom) and the unfolded state (top). Tm or Cm represent
temperature or chemical denaturant concentration at the midpoint of the unfolding
curve. From ref. [14].
2.1.1 Circular Dichroism Spectroscopy
Circular Dichroism Spectroscopy (CD) is one of the methods that allows the rapid eval-
uation of protein folding, secondary structure content and binding properties of proteins
[143]. CD is based on the interaction of circularly polarized light with molecular struc-
tures bearing chiral properties. In proteins these are accounted mostly by present mainly
in secondary structure elements, amino acid aromatic side chains and disulfide bridges
[144].
Proteins in the native state present a particular and characteristic CD spectrum. How-
ever, when they undergo conformational changes the CD spectrum changes, providing
new information about the structure of the protein. With this method, it is possible
to monitor with high sensitivity changes in secondary or tertiary structure of a protein,
depending on the range of wavelengths. The secondary structure of a protein can be
monitored in the far-UV region (190 to 250 nm). CD spectra have distinct shapes de-
pending on the predominant type of secondary structure present in the protein sample
Figure 2.2. For example, if the protein has predominantly α-helix structure it has
a characteristic peak at 222 and 208 nm. However, β-sheet structures present a peak
between 217 and 220 nm [143, 145].
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Figure 2.2: Illustration of graphs showing far-UV CD spectra associated
with various types of secondary structure. Solid line, α-helix; long dashed line,
antiparallel β-sheet; dotted line, type I β-turn; cross-dashed line, extended 31-helix or
poly (Pro) II helix; shortdashed line, irregular structure. From ref. [145].
In the near-UV region (250 nm to 320 nm) it is possible to monitor tertiary structure,
as this spectral region functions as a probe sensitive to environmental and topographic
changes in this type of structure. CD signals in the region between 255 nm to 270 nm
are assigned to phenyl groups and to phenylalanine. On the other hand, phenolic groups
of tyrosine have a particular CD signal between 275 nm and 285 nm. Indole groups of
tryptophan residues present a characteristic signal in the region between 285 nm and
305 nm [146].
CD spectroscopy has several applications and potential. It is possible, for example,
study protein stability by monitoring spectrum changes induced by alterations in the
environment conditions (temperature, pH, denaturant concentration) [145].
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2.1.2 Fluorescence Spectroscopy
Fluorescence spectroscopy is a highly sensitive method used to study protein folding and
dynamics through the analysis of the tertiary structure of proteins [142]. Most proteins
have intrinsic fluorescence, a property that is due to the presence of Tryptophan (Trp),
Tyrosine (Tyr) and Phenylalanine (Phe) residues. These aromatic residues allow the
study of protein tertiary structure based on the measurement of intensity and wave-
length emission maximum of intrinsic fluorescence of proteins. Although all of this three
residues are potential natural fluorophores, Trp is the main contributor since it has the
higher absortion at the emission wavelength (280 nm) and a higher emission quantum
yield at a wavelength of emission ranging from 300 nm to 350 nm, depending on solvent
polarity [147, 148]. Unlike Trp, Tyr and Phe residues are not particulary sensitive to
their environment and, therefore, do not provide information about the structure of the
protein. Fluorescence spectroscopy allows to evaluate the integrity of the protein ter-
tiary structure. The higher exposure to the solvent of the aromatic aminoacids results
in a deviation to higher wavelengths (deviation to red) of the emission spectra.
Besides intrinsic fluorophores we can also use extrinsic probes such Thioflavin T (ThT)
and ANS (8-anilino-1-naphthalene sulfonic acid) to study folding and amyloid forma-
tion. ThT is used as a specific probe for detection of amyloid fibrils. Amyloid fibrils
have a secondary structure composed primarily of β-sheets. This probe interacts with
this type of structures, being interspersed with them. Thus, the connection of ThT with
fibers leads to an increase in fluorescence intensity and induces a shift in the maximum
wavelength from 483 nm to 478 nm [147, 149]. On the other hand, ANS interacts with
exposed hydrophobic regions of proteins, being used to detect and characterize folding in-
termediates. This interaction induces a shift in the maximum emission wavelength, from
530 nm to 475 nm (wavelenght of excitation is 370 nm). Moreover, emission quantum
yield increases up to 100 times after this ANS–hydrophobic region interaction[147, 149].
2.1.3 Dynamic Light Scatering
Dynamic Light Scattering (DLS), is a technique used to characterize the size and the
size distribution of biomolecules in solution. It is a relatively fast method (it only takes
a few minutes to perform a measurement) and allows the analysis of particles with
sub-micrometric sizes [150].
When a light source illuminates a solution, the particles present in this solution will
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scatter the light in all directions. This method analyses the intensity and the fluctuations
of the scattered light and is able to detect them due to the Brownian motion of molecules
in solution [150]. Brownian motion is the movement of particles due to random collision
with the molecules of the liquid that surrounds the particle.
DLS works without exact knowledge of the sample concentration and has been used
with success in structural biology. The only requirement is that enough light must be
scattered to achieve sufficient statistical accuracy [150]. It should be noted that this
is a method with low resolution so in order to have a distinct separation between two
species they have to be different in terms of molecular mass. Therefore, DLS is more
appropriate to use in aggregates with large sizes than in small oligomers [151].
2.1.4 Measuring the conformational stability of a protein
In order to measure the conformational stability of a protein it is necessary to determine
the equilibrium constant and the free energy change, ∆G for the following reaction:
F ⇀↽ U (2.1)
Usually, the conformational stability is called ∆G(H2O) at 25
◦C, where H2O represents
the absence of a denaturant. There are several techniques that can be used to follow the
unfolding of a protein: UV difference spectroscopy, fluorescence and CD are the most
used. The choice of technique depend on several factors that will determine whether it is
right for the system under study. Although a particular method can be more informative,
it may require more material or be very expensive, which conditions the choice. One
should take into account three factors: i)The magnitude of the response may be of
crucial importance. Different techniques require different amounts of protein, which is an
important factor during the choice; ii)It is necessary to pick a technique and a wavelenght
for which the spectra/characteristics of the folded and unfolded conformations differ
significantly; iii)Another important factor is the signal-to-noise ratio. The greater its
value the more accurate the measurements.
Figure 2.1 shows a typical unfolding curve. It is possible to divide this type of curves in
three regions. Pre–transition region, that shows how the signal of folded protein depends
upon the denaturant; transition region, that shows how the signal change as unfolding
occurs and post–transition region, that shows how signal of unfolded protein varies with
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denaturant.
Measuring the conformational stability of a protein implies thermodynamic measure-
ments. So, it is essential that the unfolding reaction has reached equilibrium before
measurements are made and that the unfolding reaction is reversible. The unfolding
of many monomeric globular proteins has been found to closely approach a two–state
folding mechanism (see eq1). However, there may be intermediates and the folding
mechanism becomes one of three states. In the next lines it will be assumed a model of
two states, in order to facilitate the discussion. So, for a determined temperature:
fF + fU = 1 (2.2)
Where fF and fU represent the fraction of molecules in the folded and in the unfolded
conformation, respectively. Thus, the observed value of y at any point will be:
y = yFfF + yUfU (2.3)
where yF and yU represent the values of y characteristic of the folded and unfolded states,
respectively.
Combining these two equations yields:
fU =
yF − y
yF − yU (2.4)
The equilibrium constant, K, and the free energy change, ∆G, can be calculated using:
K =
fU
1− fU =
fU
fF
=
yF − y
y − yU (2.5)
and
∆G = −RTlnK = −RTlnyF − y
y − yU (2.6)
where R is the gas constant and T the absolute temperature. It should be noted that
values of yF and yU are obtained by extrapolating from the pre- and post-transition
regions.
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Thermal unfolding
The analysis of thermal unfolding curves require ∆G measurements from the narrow
temperature range where unfolding occurs to an ambient temperature. The method
used to obtain the enthalpy change is the van’t Hoff equation:
d(lnK)
d(1/T )
= −∆H
R
(2.7)
Entalphy change varies with temperature, which is expected when the heat capacities of
the products and reactants differ:
d(∆H)
d(T )
= Cp(U)− Cp(F) = ∆Cp (2.8)
It is necessary both ∆Cp and ∆H to calculate ∆G as a function of temperature. ∆H
is needed at only a single temperature, and the best to use is Tm, the midpoint of the
thermal unfolding curve, where ∆G(Tm) = 0.
With these parameters we can calculate ∆G at any temperature:
∆G(T ) = ∆Hm(1− T/Tm)−∆Cp[(Tm − T ) + T ln(T/Tm)] (2.9)
Irreversible thermal denaturation
All the formalism described above is only valid for a reversible thermal denaturation.
However, thermal unfolding denaturation can be an irreversible process. It is not possi-
ble to derive directly thermodynamic parameters from irreversible systems, as these are
under kinetic control. The irreversible thermal denaturation of a protein comprises at
least two steps: the reversible unfolding of the native protein to the denaturated form,
followed by a kinetically controlled step, leading to a final irreversible state. It was de-
veloped a formalism that allow to be established that the kinetic effects are reflected in
the scan rate dependency of the observed transitions and that these become negligible
at sufficiently high scan rates, ultimately at an infinite scan rate. Under these condi-
tions, the contribution of the irreversible step is eliminated and the observed transition
reflects exclusively the reversible component of the process, from which thermodynamic
parameters can be obtained [152].
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In this work, there are irreversible thermal denaturation transitions. For these processes,
the thermodynamic parameters calculated are named as apparent. So, instead of Tm
values we used the onset point of aggregation, named Tagg, which is the temperature
at which the protein aggregation starts. It should be noted that, even with apparent
parameters, they are quite useful for comparing experiments performed under the same
conditions.
2.2 Materials and Methods
2.3 Chemicals
All reagents were of the highest grade commercially available. All solutions were pre-
pared in water treated with the chelating material Chelex(Sigma-Aldrich). The buffers
used were oxygen-free.
2.4 Protein Expression and Purification
Wild type S100B and the mutant ∆Cys (cysteine deficient variant(C68S-C84S)) were
expressed in E.coli BL21(DE3) and purified to homogeneity, as previously described
[153]. The plasmids and the first cellular extracts for both proteins were provided by
our collabolator Guenter Fritz.
2.4.1 S100B Expression
The cDNA for human S100B was cloned into expression vector pGEMEX–2 (ampicilin
resistance). S100B protein was expressed in E.coli BL21(DE3).
Bacterial cells were grown at 37◦C in 50 mM phosphate-buffered DYT medium pH 7.4
containing 0.2% glucose. The expression was induced by the addition of 1 mM of IPTG
at an optical density OD600 nm of 0.6 and the culture was grown overnight. Cells were
harvested by centrifugation at 8000 rpm for 10 min.
2.4.2 S100B Purification
S100B protein undergo a conformational change upon Ca2+-binding that exposes a hy-
drophobic core. Based on this property the purification was performed in two steps,
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using Ca2+-dependent Hydrophobic Interaction Chromatography and subsequent Size
Exclusion Chromatography.
For protein purification, 10 g of cells were suspended in 20 mL 50 mM Tris-HCl, 5 mM
MgCl2 pH 7.6. A few crystals of DNAse I were added and cells were broken by three
passages through a French press. After cell breakage, 0.5 mM PMSF was added and
the crude extract was centrifuged at 18000 g for 35 min. A second centrifugation was
performed at 42000 rpm for 45 min. The supernatant was diluted 2-fold with 50 mM
Tris-HCl pH 7.6 and 5 mM CaCl2 was added. The diluted supernatant was then loaded
onto a phenyl-Sepharose Fast Flow Column (Amersham, GE-Healthcare) equilibrated
with 50 mM Tris-HCl, 5 mM CaCl2 pH 7.6. The column was washed with 20 volumes
of the same buffer until absorption at 280 nm reached a baseline. For S100B ∆Cys,
since it contains cysteines, 0.5mM was added to the wash buffer. Bound S100B protein
was eluted with 50 mM Tris-HCl, 10 mM EDTA pH 7.6. The obtained protein was
concentrated by ultrafiltration and loaded onto a Superdex 75 column (Amersham, GE-
Healthcare) equilibrated with 20 mM Tris-HCl, 150 mM NaCl pH 7.6.
The two proteins obtained were concentrated to 20 mg/mL by ultrafiltration with Am-
icon centricons with a 3 kDa cut-off. The aliquots were flash frozen in liquid nitrogen.
In order to evaluate the purity of the protein it was performed a 12% acrylamide SDS-
PAGE gel and were traced far-UV CD (from 190 to 260 nm)and UV-visible (from 250
to 800 nm) spectra.
S100B protein concentration was determined spectrophotometrically using the visible
absorption extinction coefficient 280=1490 M−1.cm−1. This was performed using a Shi-
madzu UV-1700 spectrophotometer at room temperature.
For all subsequent experiments protein concentration used was 0.15 mg/mL (14 µM).
The buffer used was 20 mM Tris-HCl pH 7.0.
Previous studies have determined that the cysteine to serine substitutions in S100B ∆Cys
do not compromise the overall fold but only a small part of helix HIV 1.3. Posterior to
the experiments performed during this work the structure of S100B ∆Cys was resolved
and was noticed that it had zinc bonded. Zinc was used during protein purification and
apparently it stayed bonded even with the addition of EDTA. This fact explains several
results and should be taken into account for the future work.
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2.5 Preparation of apo S100B wt
Prior to all experiments S100B wt protein was incubated with a 300-fold excess of DTT
for 2 h at 37 ◦C to reduce all cysteine residues. Metal ions were removed by addition of
0.5 mM EDTA [79]. Both EDTA and DTT were removed on a Desalting column (GE
Healthcare) equilibrated with the chosen buffer. It was concentrated by ultrafiltration
and quantified spectrophotometrically as mentioned above (see section 2.4).
2.6 Preparation of metal loaded proteins
There were prepared several protein samples with and without metal ions. To apo protein
were added 0.5 mM of EDTA or 140 µM (10 molar equivalents) of metal ions , CaCl2,
ZnCl2, CuSO4. Unless otherwise indicated, all measurements were done immediately
after the addition of EDTA or metal ions.
2.7 Circular Dichroism Spectroscopy
CD measurements were recorded in a Jasco J-815 spectropolarimeter equipped with a
Peltier-controlled thermostated cell suport using a quartz cuvette of 1 cm. The far-UV
CD spectra were traced in a wavelength range from 190 to 260 nm with the following
parameters: 200 nm/min of speed (continuous mode), 2 nm of bandwidth, 1 s of response
and an average of 10 accumulations. These spectra were acquired at 25◦C, before and
after heating as well as at 90/95/99◦C. Temperature Ramps were done following the
wavelength 222 nm. The other parameters were: 100 mdeg of sensibility, 2 nm of
bandwidth and 1 s of response. Temperature was increased in at a rate of 1◦C/min in a
range from 25 to 90, 95 or 99◦C.
2.7.1 Metal Binding Competition Experiments
Zn2+ or Cu2+ were added to apo wt and ∆Cys protein and far-UV CD-spectra were
traced at 25◦C. The samples were incubated during 1 h and another spectra were traced.
After this the second metal was added (Cu2+ or Zn2+) and a new spectra were done. For
the two-metal-loaded protein samples thermal denaturation was performed in a 25-95◦C
range. Far-UV CD spectra were also performed at 95◦C and after the sample was cooled
until 25◦C .
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2.7.2 Zinc Binding Kinetics
Zn2+ was added to apo wt and ∆Cys protein and far-UV CD-spectra were traced every
five minutes during 2 h at 25◦C.
2.8 SDS-PAGE and Native-PAGE
The SDS- and Native-PAGE analysis were performed using 15% acrylamide gels with
Mini-Protean 3 system, from Bio-Rad. The samples were prepared by adding 50% (v/v)
of loading buffer and, only in the case of SDS-PAGE, incubated at 100◦C for 10 minutes.
The SDS-PAGE Molecular Weight Markers used were from Amersham Biosciences (Low
Molecular Weight Calibration Kit for SDS Electrophoresis). Gels were eluted at 200 V,
were stained with Comassie Blue (USB Corporation) and bleached with an aqueous
solution of acetic acid (5%) and methanol(10%).
2.8.1 TCEP assays
Samples were incubated 1h at 37◦C with 5 mM TCEP and β-mercaptoetanol.
2.9 Fluorescence Spectroscopy
Intrinsic tyrosine measurements of S100B protein were performed on a Varian Cary
Eclipse instrument. Temperature was kept at 25◦C by a Peltier-controlled cell support.
Emission spectra upon 275 nm excitation were recorded using 10 nm excitation and
emission slits.
S100B protein does not have Trp residues and only have one Tyr which has a low
quantum yield. The measurements performed do not allow to distinguish between the
native state and denatured state (data not shown). Therefore, the studies using this
technique did not proceed.
2.10 Dynamic Light Scattering
The molecular diameter of S100B protein at 0.15 mg/mL was assessed using a Malvern
Instruments Zetasizer Nano ZS instrument equipped with a 633 nm laser. Temperature
was increased in a range between 25◦C and 95◦C and controlled using a Peltier-controlled
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thermostatized cell support. Before each measurement, samples were filtered through a
0.22 µM membrane. Results were analyzed with Malvern Instruments DTS software.
During DLS experiments protein stock ended so it was not possible to perform a complete
study of S100B wt and ∆Cys protein in several metal-loaded states.

Chapter 3
Results and Discussion
3.1 Metal binding to S100B induces structural
changes
S100B protein has the ability to bind Ca2+, Cu2+ and Zn2+. Metal ions play an im-
portant role in structure and, therefore, in the function of S100B protein. Thus, it
becomes important to understand metal-binding mechanisms and how do they induce
conformational changes in this S100B.
In order to investigate the effect of metal ion binding on the structure of S100B, the wild
type (wt) and a cysteine-to-serine mutant, ∆Cys protein, were studied in apo (metal
free) and holo (metal loaded) forms. These conformational studies were performed using
far-UV circular dichroism (CD). S100B wt and ∆Cys proteins samples were prepared in
several metal load conditions. In addition to apo protein, Ca2+, Cu2+ and Zn2+metal
ions were added to different samples . Moreover, addition of EDTA was used as a
negative control.
It should be noted that, as mentioned previously (section 1.3), the replacement of cys
by ser does not affect the overall fold nor the Ca2+ affinity.
The CD spectra of all protein preparations at 25◦C are typical of α-helix proteins
(Figure 3.1). However, the intensity of the spectra and, therefore, the content on
secondary structure, depends on the protein (S100B wt or ∆Cys) and on metal load
conditions.
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(a) S100B wt (b) S100B ∆Cys
Figure 3.1: CD-monitored S100B conformational changes upon metal bind-
ing Representative CD spectra of S100B wt (a) and ∆Cys (b) in several metal load
conditions: apo(black line), Ca2+ (green line), Cu2+ (blue line), Zn2+ (grey line) and
EDTA (orange line)
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Conformational changes induced by metal ions on S100B wt
CD spectra of S100B wt protein (Figure 3.1a) show that the addition of EDTA to
S100B wt apo protein does not elicit significant secondary structure changes. EDTA
addition was a negative control used to make sure that the apo sample is free of metals.
CD spectra corroborates that. However, after metal binding the far-UV CD spectra
of the protein undergo changes. Cu2+-binding induces a small increase in secondary
structure content, but is upon Ca2+-binding that the increase in α-helical content is
higher. On the other hand, Zn2+-binding has the opposite effect observed for Ca2+ and
Cu2+, as it significantly decreases the secondary structure of the S100B. It is known that
Ca2+-binding to S100B protein induces conformational changes, which is corroborated
by CD spectra of Figure 3.1a. At 25◦C, Zn2+ decreases the content of secondary
structure but Cu2+ does not have a significant effect.
Conformational changes induced by metal ions on S100B ∆Cys
S100B ∆Cys presents a different behaviour when compared to S100B wt (Figure 3.1b).
In this case, far-UV CD-spectrum of S100B ∆Cys apo protein is quite different from the
negative control (EDTA). Upon EDTA addition, it is observed a significant decrease in
secondary structure content. This can be justified because S100B ∆Cys apo, as was
discovered recently (see section 2.4), has Zn2+ bonded. Zn2+ stabilizes the α-helix HIV
so the apo sample has a different intensity in far-UV CD spectrum. Altough EDTA was
not able to remove all the Zn2+ ions during protein purification, it can remove some
metal ions from S100B ∆Cys, leading to a decrease in far-UV CD spectrum signal.
Ca2+ binding gives rise to a spectrum very similar with the apo protein one, being only
slightly less intense. Binding of Cu2+ and Zn2+ to the protein results in a conformational
change inducing the highest increase in α-helical content. The two spectra are completely
overlapped which makes sense if we take into account that the binding sites for these
ions are the same.
It should be noted that for S100B wt protein the binding of Cu2+ and Zn2+ does not
elicit the same conformational changes, at least in terms of signal intensity. Therefore,
for the S100B wt protein there could exist another factor that makes this metal-binding
effect change.
In general, the content of secondary structure of S100B wt protein is lower than the
one for S100B ∆Cys. This may due to the fact that the S100B wt protein requires
preparation (section 2.5) before experiments and this manipulation may introduce minor
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destabilization on protein. Therefore, the intensity of the S100B wt and ∆Cys spectra
should not be compared.
3.2 Cu2+ and Zn2+ binding to S100B decreases
thermal stability
Metal binding to S100B protein induces not only conformational changes but affects
also the stability of the protein. The conformational stability of S100B wt and ∆Cys,
in the apo and distinct metallated states was investigated by temperature-induced un-
folding assays. Temperature of thermal denaturation experiments was modified in the
25-90/95/99◦C range. The far-UV CD-spectra were traced at 25◦C, before and after
heating and also at 90/95/99◦C.
3.2.1 Thermal stability of native S100B
The T-Ramp of S100B wt apo and the negative control (EDTA) samples are overlapped
and is not visible any transition (Figure 3.2f). Moreover, the far-UV CD spectra of both
samples present the same behaviour (Figure 3.2a and Figure 3.2b) . The 90◦C and
25◦C cooled spectra suggest a conformational change: a loss of α-helical content and
a gain of β-sheet secondary structure. Although not completely identical, the S100B
protein loaded with Ca2+ has a very similar behavior with that of the previous sam-
ples. The T-Ramp has a visible transition and is not overlapped with the other two.
However, the conformational changes induced by thermal denaturation are, apparently,
the same(Figure 3.2c). Ca2+ induces a conformational change in S100B protein which
can explain the presence of a transition in the T-Ramp of Ca2+-loaded protein. For
these three protein samples there was no evidence of aggregates. The T-Ramp and
the CD-spectra of Cu2+ and Zn2+-loaded samples are different from the ones described
above (Figure 3.2d, 3.2e and 3.2f). The far-UV CD spectra after thermal denatu-
ration (95◦C/99◦C and 25◦C cooled sample) (Figure 3.2d and 3.2e) indicate a total
denaturation of protein. The CD signal intensity is almost zero, which represents loss
of α-helix secondary structure. The T-Ramps of both samples present a well-defined
transition. For these samples it was observed a large amount of aggregates, which is in
agreement with the CD spectra measured after denaturation. As mentioned in section
2.1.4 it is not possible to calculate the Tm for thermal unfolding irreversible systems.
In this case, we will use the temperature of aggregation (Tagg) instead of Tm. For Cu
2+
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(a) S100B wt apo (b) S100B wt + 0.5 mM EDTA
(c) S100B wt + 1:10 Ca2+ (d) S100B wt + 1:10 Cu2+
(e) S100B wt + 1:10 Zn2+ (f) S100B wt T-Ramp overlay
Figure 3.2: CD-monitored thermal denaturation of S100B wt. Representa-
tive spectra at different temperatures in several metal load conditions (a)-(e); T-Ramp
overlay in several metal load conditions (f).
46 CHAPTER 3. RESULTS AND DISCUSSION
and Zn2+ loaded samples the Tagg is 68
◦C and 65◦C, respectively. As S100B wt apo
protein does not present a transition, we can not compare its Tm with Tagg for Cu
2+
and Zn2+ samples. However, we can conclude that S100B wt protein is more stable in
the apo state than when it is loaded with Cu2+ or Zn2+, as for the first case it does not
aggregate. The study of thermal stability of holo and apo S100B wt suggests that the
different samples can be separated into different groups. Holo samples do not present
aggregates after thermal denaturation which make possible a kind of reversibility. Af-
ter heating the samples they do not unfold but suffer a conformational change instead.
Ca2+-loaded S100B wt suffers a conformational change before heating, which is trans-
lated into a visible transition in T-Ramp. However, the Ca2+-induced conformational
change does not influence the presence of aggregates. Cu2+ and Zn2+-loaded samples
can be considered an individual group since both of them form aggregates after thermal
denaturation and the CD spectra show that protein does not have the ability to re-
cover the fold after heating. The binding of these two metals apparently induce a large
conformational change that alters the stability of the protein.
3.2.2 Thermal stability of S100B ∆Cys
The thermal stability study of S100B ∆Cys upon metal binding reveals a similar be-
haviour when compared with S100B wt protein. S100B ∆Cys apo and Ca2+-loaded are
samples very similar between them. The addition of EDTA does not induce significant
changes. The three T-Ramps present the same shape and are only different in terms
of signal intensity, which is normal if we take into account the CD spectra at 25◦C.
Moreover, these T-ramps do not present any visible transition (Figure 3.3f). After
thermal denaturation these samples have the ability to recover some secondary struc-
ture content. In fact, after denaturation it is visible some reversibility in CD spectra,
however, protein suffers a conformational change, which is reflected in an increase of
β-sheet secondary structure. These changes that protein undergoes are visible in the
CD spectra of samples after heating and after cooling (Figure 3.3a, 3.3b and 3.3c).
Despite this conformational change, apo and Ca2+-S100B ∆Cys samples do not present
aggregates after thermal denaturation. The negative control does not present protein
aggregation also. Again, as occurs in S100B wt protein, Cu2+ and Zn2+ samples could
be inserted into a different group since they present a different behaviour in these ex-
periments. The thermal denaturation profile are different from the other samples as
well as the capacity of reversibility (Figure 3.3f). S100B ∆Cys loaded with Cu2+ and
Zn2+ form aggregates and do not present α-helix content in far-UV CD-spectra at 90◦C
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and 25◦C cooled (Figure 3.3d and 3.3e). In fact, these two spectra have an intensity
near zero suggesting that the protein is denaturated. Thermal denaturation ramp of
Cu2+-loaded protein exhibit a visible transition and the Tagg =80
◦C. The Zn2+ sample
present a very well defined transition profile in T-Ramp but the Tagg is lower, 69
◦C.
The main observations that can be taken from these results are that altough S100B
wt and ∆Cys protein undergo a conformational change upon Ca2+ binding this not
affect the stability of the protein. Moreover, thermal denaturation does not induce the
formation of aggregates but converts some of the α-helix content in β-sheet secondary
structure. On the other hand, Cu2+ and Zn2+ binding to S100B protein induce a large
conformational change, which is reflected in terms of stability. Upon Cu2+ or Zn2+
binding, thermal denaturation experiments showed that the protein tends to denaturate
and aggregate. Although thermal stability of S100B wt loaded with Cu2+ or Zn2+ is not
very different, the S100B ∆Cys protein presents almost 15◦C of difference. For this last
protein, Cu2+ is much more stable than Zn2+.
3.3 Copper and Zinc have different effects on
S100B structure and stability
The results of the previous section showed that Cu2+ and Zn2+ binding to S100B protein
have a different effect in conformation and stability. The behaviour presented by the
samples loaded with these two metals was quite different from Ca2+-loaded or apo pro-
tein. So, in order to better understand the role of these metals in protein structure and
stability a new set of experiments was done. It has been reported that the binding of
Cu2+ and Zn2+ frequently occurs at the same binding sites, but with different affinities.
These new CD experiments pretended to study Cu2+ and Zn2+ binding competition and
to clarify their role together on S100B structure and stability.
3.3.1 Effect on S100B secondary structure
The structural changes induced by Cu2+ and Zn2+ on S100B protein were studied by
performing far-UV CD-spectra. For S100B wt and ∆Cys proteins each metal ion was
incubated for 1 h and then the second metal was added.
The wt protein loaded with Zn2+ does not loss signal in far-UV CD spectrum, even
after 1 h of incubation. However, when Cu2+ is added to this sample, it is observed a
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(a) S100B ∆Cys apo (b) S100B ∆Cys + 0.5 mM EDTA
(c) S100B ∆Cys + 1:10 Ca2+ (d) S100B ∆Cys + 1:10 Cu2+
(e) S100B ∆Cys + 1:10 Ca2+ (f) S100B ∆Cys T-Ramp overlay
Figure 3.3: CD-monitored thermal denaturation of S100B ∆Cys. Representa-
tive spectra at different temperatures in several metal load conditions (a)-(e); T-Ramp
overlay in several metal load conditions (f).
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conformational change, indicated by a decrease in α-helical content (Figure 3.4a). On
the other hand, the incubation of 1 h with Cu2+ results in a significant loss of α-helix
signal (Figure 3.4b). The later addition of Zn2+ does not present any changes when
compared to the 1h incubated sample.
S100B ∆Cys incubation for 1h with Zn2+ gives rise to a significant loss of signal, which
indicates a decrease in α-helical content (Figure 3.4c). Nevertheless, the signal of
far-UV CD spetrum increases upon Cu2+ binding, but not to the initial values. Cu2+
incubation and later addition of Zn2+ to ∆Cys protein does not affect significantly the
secondary structure content (Figure 3.4d).
These results suggest that Cu2+ has the ability to displace Zn2+ from his binding site
and that the effects of these two metal ions are different, depending on the protein. For
S100B wt, Zn2+ incubation does not affect the stability of the protein. However, Cu2+
has a destabilizing effect and is able to exert that because can displace Zn2+. Zn2+ is
not able to displace Cu2+ and his effect is not visible if the sample has already Cu2+.
On the other hand, for S100B ∆Cys protein the metal ions effect is the opposite. Zn2+
incubation is destabilizing and Cu2+ has a stabilizer effect. Moreover, Cu2+ has also the
ability to displace Zn2+ from the binding site.
3.3.2 Effect on S100B thermal stability
In order to study the Cu2+ and Zn2+ binding competition on S100B stability T-Ramp
experiments with the two metals were done.
The T-Ramp of S100B wt protein loaded with Zn2+ presents a Tagg around 65
◦C (Figure
3.5a). However, when it has Zn2+ and Cu2+ bonded, protein aggregation begins sooner,
at 30◦C. As the two metal loaded T-Ramp does not present a visible transition, the Tagg
was estimated taking into account the increase in High Tension Voltage, an indicator of
aggregation (data not shown). It should be noted that the shape of the two T-Ramps
is very different, which is reflected in protein stability . The far-UV CD spectra of Zn2+
and Cu2+ loaded sample after thermal denaturation are typical of β-sheet secondary
structure (Figure 3.4a). Apparently, although Zn2+ + later Cu2+ addition sample
is less stable, after heating it presents an higher content in secondary structure, when
compared with Zn2+-loaded S100B wt protein. This is curious because Cu2+ destabilizes
S100B wt protein.
S100B wt loaded with Cu2+ starts to aggregate, during thermal denaturation, at 68◦C.
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(a) S100B wt loaded with Zn2+ + later Cu2+ addi-
tion
(b) S100B wt loaded with Cu2+ + later Zn2+ ad-
dition
(c) S100B ∆Cys loaded with Zn2+ + later Cu2+
addition
(d) S100B ∆Cys loaded with Cu2+ + later Zn2+
addition
Figure 3.4: Metal binding competition on S100B structure. Representative CD
Spectra of S100B wt and ∆Cys loaded with Cu2+ and Zn2+ metal ions.
3.4. ZN2+ BINDING KINETICS 51
When Zn2+ is added to this sample Tagg changes to 40
◦C (Figure 3.5b). In this case, the
shape of the T-Ramps are more similar than the anterior one. However, the stability of
the two samples are very different. Moroever, contrary to what happened to the sample
loaded with Zn2+ + later Cu2+ addition, the CD spectra at 95◦C and 25◦C cooled have
an intensity near zero which suggests that the protein is totaly unfolded (Figure 3.4b).
Zn2+ addition induces a decrease in thermal stability and makes impossible a recovery
of secondary structure.
When S100B ∆Cys loaded with Zn2+ is submitted to thermal denaturation, it starts to
aggregate at 66◦C. Nevertheless, the consequent addition of Cu2+ changes the stability.
In this case, the Tagg is 71
◦C (Figure 3.5c). The two T-Ramps are very similar, which
not occurs in S100B wt samples. After heating the CD signal decreases to values near
zero, so the protein is in the denaturated state (Figure 3.4c).
S100B ∆Cys protein loaded with Cu2+ has a Tagg near 80
◦C (Figure 3.5d). However,
when Zn2+ is added the aggregation during thermal denaturation starts at 74◦C. Once
again the 95◦ and 25◦C cooled CD spectra present values near zero (Figure 3.4d).
The effect of Cu2+ and Zn2+ binding on S100B structure and stability, in particular the
results presented in this section, are resumed in Figure 3.6. Taking into account these
results, it can be considered that Cu2+ binding to S100B affects the conformation of
S100B protein but not of S100B ∆Cys. Moreover, for S100B protein, subsequent Zn2+
addition has no effect on folding but it affects the stability. On the other hand, for
S100B ∆Cys protein, subsequent Zn2+ addition has no effect on folding and it induces
a minor destabilization on the protein. Zn2+ binding affects the conformation of S100B
∆Cys but not the secondary structure of S100B wt. It should be also mentioned that
the subsequent Cu2+ addition to S100B wt protein has a minor effect on folding but is
highly destabilizing. In the case of S100B ∆Cys, Cu2+ addtion has the ability to partly
restores folding and stability of the protein.
3.4 Zn2+ Binding Kinetics
Zn2+-bindig to S100B protein has an important role in terms of conformation and sta-
bility. As previously mentioned Cys to Ser mutation does not affect the overall fold.
However, helix HIV , where Zn
2+ binds, becomes truncated and the C-terminal is un-
structured. This fact can interfer with Zn2+-binding to S100B and, in particular, can
introduce a difference in Zn2+ binding kinetics between holo and apo S100B protein.
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(a) S100B wt loaded with Zn2+ + later Cu2+ addi-
tion
(b) S100B wt loaded with Cu2+ + later Zn2+ ad-
dition
(c) S100B ∆Cys loaded with Zn2+ + later Cu2+
addition
(d) S100B ∆Cys loaded with Cu2+ + later Zn2+
addition
Figure 3.5: Effect of metal binding competition on S100B stability. Represen-
tative CD T-Ramps of S100B wt and ∆Cys loaded with Cu2+ and Zn2+.
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Figure 3.6: Effect of metal binding competition on S100B structure and
stability.
In order to study Zn2+-binding to S100B wt and ∆Cys protein the CD signal of both
proteins was followed at 222 nm during 2 h. After an initial CD spectra at 25◦C of S100B
wt apo protein, Zn2+ was added. The binding of Zn2+ induces an immediate increase
in CD signal (Figure 3.7a). This fact suggests that Zn2+ binding to S100B wt protein
occurs immediately after its addition. However, the increase in CD signal at 222 nm is
only <5%, which is not significant. On the other hand, the addition of Zn2+ to S100B
∆Cys apo protein does not induce an immediate response in terms of CD signal (Figure
3.7b). This could be explained taking into account the fact that S100B ∆Cys protein
already have Zn2+ and if there is an effect it could not be seen in this sample. In order
to better understand the kinetics of Zn2+ binding and the difference between S100B wt
and ∆Cys protein it should be prepared a real apo S100B ∆Cys protein.
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(a) S100B wt CD signal at 222 nm (b) S100B ∆Cys CD signal at 222 nm
Figure 3.7: Zn2+-binding kinetics Representative CD signal at 222 nm of Zn2+-
binding to S100B wt and ∆Cys
PAGE: S100B ∆Cys – Effect of TCEP
Lane 1 2 3 4 5 6 7 8 9 10 11
Control + + ‐ ‐ ‐ ‐ ‐ ‐ + ‐ ‐
2+Ca ‐ ‐ + + ‐ ‐ ‐ ‐ ‐ ‐ ‐
Zn2+ ‐ ‐ ‐ ‐ + + ‐ ‐ ‐ ‐ ‐
Cu2+ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ + +
EDTA ‐ ‐ ‐ ‐ ‐ ‐ + + ‐ ‐ ‐
TCEP ‐ + ‐ + ‐ + ‐ + ‐ ‐ +
Figure 3.8: Effect of metal binding in cys-dependent dimerization. Native-
PAGE for S100B ∆Cys protein loaded with Ca2+, Cu2+ and Zn2+ in the presence of
absence of TCEP. Control corresponds to S100B ∆Cys apo protein. EDTA is the nega-
tive control.
3.5 Effect of metal binding in cys-dependent
dimerization
TCEP is a reducing agent capable to protect thiol groups from oxidation by breaking
disulfide bonds. S100B has two cys residues so, if not reduced, it can form disulfide
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PAGE: S100B wt – Effect of TCEP
Lane 1 2 3 4 5 6 7 8 9 10 11
Control + + ‐ ‐ ‐ ‐ ‐ ‐ + ‐ ‐
C 2+a ‐ ‐ + + ‐ ‐ ‐ ‐ ‐ ‐ ‐
Zn2+ ‐ ‐ ‐ ‐ + + ‐ ‐ ‐ ‐ ‐
Cu2+ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ ‐ + +
EDTA ‐ ‐ ‐ ‐ ‐ ‐ + + ‐ ‐ ‐
TCEP ‐ + ‐ + ‐ + ‐ + ‐ ‐ +
Figure 3.9: Effect of metal binding in cys-dependent dimerization. Native-
PAGE for S100B wt protein loaded with Ca2+, Cu2+ and Zn2+ in the presence of absence
of TCEP. Control corresponds to S100B wt apo protein. EDTA is the negative control.
bonds with other subunits or proteins. In order to study the role of metal binding in
cys-dependent dimerization of S100B protein the effect of TCEP was studied. As it
was expected, the presence of TCEP does not affect the migration of S100B ∆Cys in
the gels. In fact, all metal-loaded samples present the same pattern in a native gel
(Figure 3.8). On the other hand, for S100B wt protein, it can be observed a different
behaviour (Figure 3.9). In this case, the samples with and without TCEP migrate in
a different pattern. The effect of TCEP addition is the same for all protein samples
except for S100B wt loaded with Cu2+ (Figure 3.9). Cu2+ binding showed two distinct
bands, the more intense with a higher molecular mass, when compared with the other
metal loaded samples. S100B wt protein loaded with Cu2+ and in the presence of TCEP
presents only one band.
S100B protein incubated with Ca2+, Cu2+ and Zn2+ and in the presence or abscense
TCEP was analyzed by SDS-PAGE under non-reducing conditions. All samples a band
near 6.5 kDa (monomer) except S100B wt protein loaded with Cu2+ that has a molecular
mass of 23 kDa (Figure 3.10).
It has been reported that cys residues are not necessary for the noncovalent dimerization
of S100B [154]. Although S100B exists as a noncovalent dimer in solution this disulfide-
linked dimer only occurs in the presence of Cu2+, suggesting that only Cu2+ (and not
Zn2+ or Ca2+) has an important role in disulfide bond formation between S100B subunits.
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SDS‐PAGE (non reducing): S100B wt & ∆Cys – Effect of TCEP
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Figure 3.10: Effect of metal binding in cys-dependent dimerization. SDS-
PAGE for S100B wt protein loaded with Ca2+, Cu2+ and Zn2+. Control wt is S100B wt
apo protein. Control ∆Cys is S100B ∆Cys apo protein. EDTA is the negative control.
3.5. EFFECT OF METAL BINDING IN CYS-DEPENDENT DIMERIZATION 57
These results are in agreement with Lee and coworkers [155] that described the copper-
dependent formation of disulfide-linked dimer of S100B.

Chapter 4
Concluding Remarks
S100B is the most abundant soluble protein in the human brain, being highly expressed in
astrocytes. Besides Ca2+ it has also the ability to bind Cu2+ and Zn2+. These metals are
present in the synaptic space at high levels and are involved in several neurodegenerative
disorders, including AD [139]. S100B protein is involved in several pathological processes
in which metal homeostasis is imbalanced leading to a modified protein function. In fact,
AD has been the most extensively studied neurodegenerative disease regarding S100B
pathology. Moreover, it is well known that metal ions, and in particular Cu2+ and Zn2+,
are also involved in the disease playing an important role on its development. These
metal ions have also an important role in the regulation and, therefore, in the function
of S100B protein. However, their consequences on protein conformation and stability
are not characterized.
This work extensively address the effects of metal binding on the folding and stability of
S100B protein. With this purpose we have studied the wild type form of human S100B
as well as Cys-to-Ser mutated variant, S100B ∆Cys. The structural changes induced by
metal ions in S100B and the thermal stability of the protein were studied using far-UV
circular dichroism (CD). The CD spectra of S100B wt protein in the apo and holo state
suggest that not only different metals induce different conformational changes but also
that these changes are different depending on the protein (wt or ∆Cys). Moreover, the
stability of the protein monitored by thermal denaturation is quite different in distinct
metal loaded samples.
S100B protein undergo substantial conformational and thermal stability changes upon
Zn2+ and Cu2+-binding. Unlike Ca2+, these two metal ions are responsible for destabiliz-
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(a) S100B apo or Ca2+-loaded
(b) S100B Cu2+ or Zn2+-loaded
Figure 4.1: Model of S100B thermal denaturation mechanisms upon metal
binding.
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ing the protein leading to aggregation. On the other hand, S100B apo and Ca2+-loaded
protein do not aggregate. However, these two samples suffer a conformational change
after thermal denaturation. In fact, a part of the α-helix secondary structure content is
lost and it is visible the appereance of new β-sheet structural elements. These effects
were observed for both S100B proteins and are represented in Figure 4.1a and Figure
4.1b, a model that we build up taking into account the results obtained for conforma-
tional and thermal stability of S100B wt protein upon metal ion binding. The study
of Cu2+ and Zn2+ binding competition revealed that Cu2+ has the ability to displace
Zn2+ from the binding site distabilizing S100B wt protein (∆Tagg = 35
◦C). However, for
S100B ∆Cys, although Cu2+ also displaces Zn2+, it has the opposite effect, stabilizing
the mutated protein (∆Tagg = −5◦C) However, for all of these samples protein aggre-
gation was observed. Figure 4.2 and Figure 4.3 are two models that exemplify the
mechanisms described above. We also observed that Cu2+, but not Zn2+ or Ca2+, has
the ability to promote intermolecular disulfide bond formation between S100B subunits.
All together, these results led us to hypothesize that metal induced conformational
changes may account for the buildup of conformers that have increased oligomerization
propensity and that this may play a role in S100B function and on its interactors. This
possibility is particularly relevant considering the interplay of S100B with amyloid-β
peptide, which are suggestive of an even more interesting engagement in AD.
The experimental studies presented here brought a valid contribution to clarify the mech-
anisms underlying metal ion modulation of S100B conformation and stability. However,
many questions remain unanswered. So, in order to understand the interaction of metal
ions with this cytokine should be carried out other experiments. Monitoring thermal de-
naturation using Dynamic Light Scattering would be an important contribute to better
understand S100B aggregation modulated by metal binding. Moreover, it could pro-
vide an overview of the S100B oligomeric species formed upon metal binding. Chemical
denaturation could also be usefull to better characterize S100B stability and to deter-
mine thermodynamic parameters. In order to realize the role of cysteines in fibrillation
kinetics of S100B protein ThT fluorescence assays would be helpful. The interaction
between S100B, A-β and RAGE should also be studied in order to establish the possible
involvement of S100B protein in synaptic protein aggregation in neurodegeneration, in
particular on AD.
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Figure 4.2: Model of S100B wt metal binding competition between Cu2+ and
Zn2+.
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Figure 4.3: Model of S100B ∆Cys metal binding competition between Cu2+
and Zn2+.
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